Top Markets
#1 The Bitcoin Bull The Bitcoin Bull +24.47%
#2 EXOD EXOD +18.93%
#3 Glidr Glidr +15.96%
#4 Gas Gas +11.02%
#5 Siacoin Siacoin +10.79%
#6 Arowana Arowana +8.25%
#7 Yield Basis Yield Basis +7.17%
#8 Ethereum Name Service Ethereum Name Service +6.46%
#9 Audiera Audiera +5.62%
#10 Islamic Coin Islamic Coin +5.37%
Coin of the day
The Bitcoin Bull The Bitcoin Bull
Settings
Language
ENGLISH
Currency
USD
Theme
Heat Biologics, Inc. Heat Biologics, Inc.

Heat Biologics, Inc.

HTBX
Rank in Stocks #24400
Heat Biologics, Inc. is an integrated biopharmaceutical company focused on... Heat Biologics, Inc. is an integrated biopharmaceutical company focused on creating immune-modulating therapies and vaccines. The firm's primary goal is to harness the immune system to fight a variety of illnesses, including both cancerous growths and infectious diseases. A cornerstone of their approach is the gp96 platform, which comprises two key components: ImPACT, an allogenic cell-based system designed to stimulate and proliferate T-cells as an immune activator, and ComPACT, a singular product engineered to achieve both antigen-driven T-cell activation and specific co-stimulation simultaneously. Their development pipeline includes several clinical-stage assets. HS-110 has finished enrolling patients for its Phase II trial targeting advanced non-small cell lung cancer, while HS-130 is currently in a Phase I clinical trial for advanced solid tumors. Furthermore, PTX-35, a novel T-cell co-stimulator agonist antibody that acts on DR3/TNFRSF25, is being evaluated in a Phase I clinical trial for diverse immunotherapy applications. The company is also advancing a COVID-19 vaccine, which is currently in the preclinical stage. Heat Biologics, Inc. has partnered with Dr. James Shapiro at the University of Alberta to develop a surrogate mouse version of PTX-35. The company was founded in 2008 and is headquartered in Morrisville, North Carolina.
Share Price
$2.38
Last synced: 2022-05-03
Market Cap
$61.07M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Heat Biologics, Inc. (HTBX)

Category

Healthcare
Operating Margin for Heat Biologics, Inc. (HTBX)
Operating Margin as of 2026 TTM: 0.00%
According to Heat Biologics, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Heat Biologics, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.